| Application no. and date | 01982623.9 (espacenet) (Federated) (European Patent Register), 20011116 | | Patent/reg. no. and date | DK/EP 1339409, 20080507 | | Publication date | 20030903 | | Priority no. and date | GB 0028429, 20001122 | | EP pub. no. and date |
EP 1339409 20030903 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | AST 100212-1X | | Inventor | RAZA, Ali, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
HUTCHINSON, Howard Gerard, 1800 Concord Pike,
P.O. Box 15437
Wilmington, DE 19850, US | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 3/06 (2006.01) | | Title | Anvendelse af rosuvastatin (ZD-4522) til behandling af heterozygot, familiær hypercholesterolæmi | | Int. application no. | GB2001005041 | | Int. publication no. | WO2002041895 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
